Microbot Medical Inc. announced it has completed enrollment and follow-up for 50% of patients in its ACCESS-PVI pivotal clinical trial for the LIBERTY Endovascular Robotic Surgical System, expecting to file with the FDA by the end of 2024.
AI Assistant
MICROBOT MEDICAL INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.